Osteoarthritis: Causes, Symptoms, and Progression

Osteoarthritis is the most prevalent joint disease in the United States, affecting an estimated 32.5 million adults according to the Centers for Disease Control and Prevention (CDC). Unlike inflammatory arthropathies, it originates primarily from mechanical breakdown of articular cartilage rather than autoimmune dysregulation. This page covers the biological mechanisms driving cartilage degradation, the clinical presentations that distinguish osteoarthritis from other joint conditions, and the decision thresholds that separate conservative management from surgical intervention.

Definition and scope

Osteoarthritis (OA) is a chronic, progressive musculoskeletal disorder characterized by degradation of articular cartilage, remodeling of subchondral bone, formation of osteophytes, and synovial inflammation. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) classifies it as the most common form of arthritis, distinguishing it from rheumatoid arthritis and other inflammatory joint diseases, which involve systemic immune activation rather than localized mechanical failure.

OA affects diarthrodial joints — those with a synovial membrane and a cartilage-lined articulating surface. The knee, hip, hand, and lumbar and cervical spine are the most commonly involved sites. The CDC reports that OA is a leading cause of disability among U.S. adults, and the economic burden attributed to arthritis and related conditions exceeds $300 billion annually in medical costs and lost earnings (CDC Arthritis Data).

Two broad classification categories exist:

How it works

Healthy articular cartilage is composed predominantly of type II collagen and proteoglycans, maintained by a balanced cycle of synthesis and degradation performed by chondrocytes. In OA, this equilibrium shifts toward net matrix loss through three intersecting mechanisms:

  1. Mechanical overload: Repetitive or acute stress — from obesity, joint malalignment, or prior injury — disrupts the collagen network. Chondrocytes respond by releasing catabolic enzymes, including matrix metalloproteinases (MMPs) and ADAMTS aggrecanases, which degrade proteoglycan and collagen scaffolding.
  2. Subchondral bone remodeling: As cartilage thins, the underlying bone absorbs greater mechanical load. Increased bone turnover produces sclerosis, cyst formation, and osteophyte growth at joint margins — bony outgrowths visible on plain radiograph.
  3. Synovial inflammation: Cartilage fragments shed into the joint space activate synoviocytes, which release interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). This low-grade synovitis amplifies pain signaling and accelerates cartilage catabolism, though the inflammatory burden remains substantially lower than that observed in rheumatoid disease.

The Kellgren-Lawrence (KL) grading scale, published in Annals of the Rheumatic Diseases and referenced in American College of Rheumatology (ACR) clinical guidelines, stratifies radiographic OA severity from Grade 0 (no features) to Grade 4 (severe joint space loss with large osteophytes and bony deformity). Grade 2 is generally accepted as the threshold at which radiographic findings become clinically significant.

Pain in OA is mechanistically distinct from cartilage loss alone. Cartilage itself is aneural; pain arises from subchondral bone stress, synovial distension, periarticular muscle fatigue, and sensitization of nociceptors in the joint capsule. This explains why radiographic severity does not correlate linearly with patient-reported pain intensity.

Common scenarios

The clinical presentation varies by joint and patient population. Three high-frequency patterns characterize the majority of OA encounters in orthopedic practice:

Knee OA (Gonarthrosis): Medial compartment involvement predominates, producing a varus (bowlegged) deformity in advanced cases. Patients report weight-bearing pain, morning stiffness lasting fewer than 30 minutes (a key distinction from the prolonged stiffness of inflammatory arthritis), crepitus, and episodic joint effusion. Radiographic narrowing of the medial compartment is the hallmark finding on standing anteroposterior views. Knee OA is the most common indication for total knee replacement.

Hip OA (Coxarthrosis): Pain localizes to the anterior groin, with referral to the thigh or buttock. Internal rotation loss is the earliest and most reliable physical examination sign. Hip OA progresses to total hip replacement in a substantial proportion of patients; the American Academy of Orthopaedic Surgeons (AAOS) estimates over 450,000 total hip arthroplasties are performed annually in the United States (AAOS OrthoInfo).

Hand OA: Distal interphalangeal (DIP) joints develop Heberden's nodes; proximal interphalangeal (PIP) joints develop Bouchard's nodes. First carpometacarpal (CMC) joint involvement — basal thumb arthritis — produces pain with pinch and grip. Erosive OA, a subtype affecting 10–15% of hand OA patients, features central erosions on radiograph and more pronounced inflammatory episodes.

Spinal OA affects facet joints and is closely related to degenerative disc disease and spinal stenosis, all of which can co-occur in the same lumbar segment.

Decision boundaries

The transition from one management tier to the next follows structured criteria outlined in guidelines from the ACR, AAOS, and NIAMS. Understanding these thresholds informs how orthopedic evaluations are sequenced. A complete overview of how these guidelines fit into the broader regulatory and standards environment is available at regulatory context for orthopedics.

Conservative vs. pharmacologic management: Exercise therapy and weight reduction remain first-line interventions. The ACR 2019 guidelines conditionally recommend topical NSAIDs before oral NSAIDs for knee and hand OA, given the adverse gastrointestinal and cardiovascular risk profile of systemic agents. Intra-articular cortisone injections are indicated for moderate symptomatic flares but are not disease-modifying.

Pharmacologic vs. procedural intervention: When pharmacologic control is insufficient and pain with activity-limiting disability persists for at least 3–6 months, procedural escalation is considered. Arthroscopy has a limited role in primary OA; landmark trials — including the 2002 Moseley trial published in the New England Journal of Medicine — demonstrated no significant benefit of arthroscopic lavage or debridement over sham surgery in knee OA. Physical therapy and rehabilitation remain effective across all disease stages.

Procedural vs. surgical (arthroplasty) threshold: Joint replacement is indicated when:
1. Radiographic evidence reaches KL Grade 3–4
2. Pain is refractory to 6 months of optimized non-surgical care
3. Functional limitation affects activities of daily living
4. The patient's overall health permits surgical risk

The AAOS clinical practice guideline on knee OA and the ACR provide explicit strength-of-recommendation ratings for each intervention tier. The full scope of orthopedic care pathways that apply to OA management is mapped across the orthopedics authority reference index.

Age alone does not constitute a contraindication for arthroplasty; functional status, bone quality (assessed via DEXA scanning in patients with concurrent osteoporosis), and cardiovascular clearance are the operative determinants.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)